MicroRNA signature inBCR–ABL1-like andBCR–ABL1-positive childhood acute lymphoblastic leukemia: similarities and dissimilarities
- 14 February 2014
- journal article
- letter
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 55 (8) , 1942-1945
Abstract
Childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is a heterogeneous disease in which the 5-year event-free survival rates are currently above 80% [1]. Yet, some genetic subtypes of...Keywords
This publication has 14 references indexed in Scilit:
- MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemiaHaematologica, 2011
- Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005Journal of Clinical Oncology, 2010
- Reprogramming of miRNA networks in cancer and leukemiaGenome Research, 2010
- Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004Leukemia, 2009
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Blood, 2008
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosNature, 2008
- microRNAs in Vertebrate Physiology and Human DiseaseAnnual Review of Genomics and Human Genetics, 2007
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007
- The role of microRNAs in normal hematopoiesis and hematopoietic malignanciesLeukemia, 2006